ZURICH (Reuters) – Novartis Chief Executive Joseph Jimenez will retire in 2018, with chief drug developer Vasant Narasimhan taking over as CEO starting in February, the Swiss drugmaker said on Monday.

Continue reading on Reuters

Leave a Reply

Your email address will not be published.